| Drug Type TCR-T Cell therapy | 
| Synonyms JWATM 213, JWATM-213, JWATM213 | 
| Target | 
| Action modulators | 
| Mechanism AFP modulators(Alpha-fetoprotein modulators) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization | 
| License Organization | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Hepatocellular Carcinoma | Preclinical | China  | 30 Jan 2022 | 





